Results 41 to 50 of about 55,710 (206)

Correia repeat enclosed elements and non-coding RNAs in the Neisseria species [PDF]

, 2016
Neisseria gonorrhoeae is capable of causing gonorrhoea and more complex diseases in the human host. Neisseria meningitidis is a closely related pathogen that shares many of the same genomic features and virulence factors, but causes the life threatening ...
Cook, Richard T., Nebel, Jean-Christophe, Roberts, Sabrina, Shah, Mahwish, Snyder, Lori A. S., Spencer-Smith, Russell   +5 more
core   +2 more sources

Engineered Probiotics: The Next‐Generation Therapeutics to Combat Antibiotic‐Resistant Bacterial Infections

Food Frontiers, EarlyView.
Engineered probiotics secretes fusion proteins which potentially neutralized the toxins secreted by other microbial communities. ABSTRACT On a global scale, the escalating burden of infectious diseases, predominantly attributed to bacterial pathogens, especially drug‐resistant strains, has progressed into a critical concern for clinical management and ...
Indu Singh, Raz Abdulqadir, Indira Kumari Verma, Yashika Awasthi, Arun Ratn, Juhi Sharma, Manmeet Rawat, Megh Singh Dhakad, Jasbir Dalal, Yash Gupta, Bhisham Narayan Singh, Divakar Sharma   +11 more
wiley   +1 more source

Adjuvants : an essential component of neisseria vaccines [PDF]

, 2009
Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis ...
Acevedo, R., Balbao, J., Cabrera, O., Cuello, M., del Campo, J., Ferro, Valerie A., Gonzales, E., Romeu, B., Zayas, C.   +8 more
core  

Molecular imprinting for neurology: Materials, applications, and limitations

Ibrain, EarlyView.
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma, Yingqi Ma, Claudia Marino, Alessandro Poma   +3 more
wiley   +1 more source

Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case

Human Vaccines & Immunotherapeutics, 2018
Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey.
Gönül Tanır, Yasemin Ozsurekci, Jay Lucidarme, Sevgi Yaşar Durmuş, Aiswarya Lekshmi, Özlem Akisoglu, Ahmet Emre Aycan, Ray Borrow, Mehmet Ceyhan   +8 more
doaj   +1 more source

Development of group B meningococcal vaccine: a progress review

Zhongguo gonggong weisheng, 2022
Epidemic cerebrospinal meningitis is a respiratory infectious disease caused by Neisseria meningitidis, most commonly manifesting as meningitis and septicaemia.
Wei ZHAO, Shuang BAI, Yan-li KANG
doaj   +1 more source

Development of Multi-Locus Variable Number Tandem Repeat Analysis for Outbreak Detection of Neisseria meningitidis [PDF]

, 2006
Neisseria meningitidis is a major cause of septicemia and meningitis worldwide. Traditional typing methods like pulsed-field gel electrophoresis (PFGE) for identifying outbreaks are subjective and time consuming.
Price, Alicia Anne
core  

Pharyngeal carriage of Neisseria species in the African meningitis belt. [PDF]

, 2016
OBJECTIVES: Neisseria meningitidis, together with the non-pathogenic Neisseria species (NPNs), are members of the complex microbiota of the human pharynx.
Ali, Oumer A, Aseffa, Abraham, Bennett, Julia S, Borrow, Ray, Bugri, Akalifa, Collard, Jean-Marc, Dano, Ibrahim D, Daugla, Doumagoum M, Diallo, Aldiouma, Diallo, Kanny, Dieng, Marietou, Gadzama, Galadima, Gamougam, Kadidja, Greenwood, Brian M, Issaka, Bassira, Maiden, Martin CJ, Manigart, Olivier, Mbainadji, Lodoum, Mihret, Adane, Nascimento, Maria, Omotara, Babatunji A, Osei, Isaac, Quaye, Stephen L, Rebbetts, Lisa S, Sambo, Zailani B, Sow, Samba O, Stuart, James M, Tamboura, Boubou, Timbine, Youssouf, Trotter, Caroline, Watkins, Eleanor R, Woukeu, Arouna   +31 more
core   +1 more source

Sutimlimab in Patients With Cold Agglutinin Disease (CAD): Results From a Managed Access Program

European Journal of Haematology, EarlyView.
ABSTRACT Cold agglutinin disease (CAD) is a low‐grade lymphoproliferative disorder accounting for 15%–30% of patients suffering from autoimmune hemolytic anemias. The clonal B cells produce autoantibodies primarily of the IgM‐κ class that cause agglutination of red blood cells (RBCs) at temperatures ≤ 37°C and activate the classical complement pathway ...
Sandra Maria Frey, Pauline Halberstadt, Ferras Alashkar, Veronika Lenz, H. Christian Reinhardt, Alexander Röth   +5 more
wiley   +1 more source

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009. [PDF]

, 2016
In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation ...
Anderson, Raydel, Blain, Amy, Clark, Thomas, Cohn, Amanda, Farley, Monica, Harcourt, Brian, Harrison, Lee, Lynfield, Ruth, MacNeil, Jessica, Mandal, Sema, Mayer, Leonard, Miller, Lisa, Nichols, Megin, Petit, Sue, REINGOLD, Arthur L., Schaffner, William, Thomas, Ann, Wu, Henry, Zansky, Shelley   +18 more
core   +2 more sources